Boston Scientific has completed its acquisition of EndoChoice Holdings, the company announced today.
Boston Scientific (NYSE:BSX) has completed its acquisition of EndoChoice Holdings, the company announced today. EndoChoice is now part of Boston Scientific’s endoscopy division.
According to the press release:
“The two organizations announced a definitive agreement on September 27, 2016 for Boston Scientific to acquire the EndoChoice business at a cash price of $8.00 per share for an approximate total of $210 million.”
Art Butcher, the senior VP of Endoscopy at Boston Scientific, said the following:
“We are excited to provide physicians more comprehensive solutions to help assess, diagnose and treat patients with GI conditions. Boston Scientific is a leader in the field of endoscopy and we are committed to providing innovative products and services to meet the changing and growing needs within the field.”